The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2022, Issue -, Pages 1-19
Publisher
Hindawi Limited
Online
2022-09-07
DOI
10.1155/2022/3790721
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial damage and activation of the cytosolic DNA sensor cGAS–STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice
- (2022) Meiling Yan et al. Cell Death Discovery
- Glucose Fluctuations Aggravate Myocardial Fibrosis via the Nuclear Factor-κB-Mediated Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation
- (2022) Zhen-Ye Zhang et al. Frontiers in Cardiovascular Medicine
- Favorable effect of rivaroxaban against vascular dysfunction in diabetic mice by inhibiting NLRP3 inflammasome activation
- (2022) Qing Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
- (2021) Dario Giugliano et al. Cardiovascular Diabetology
- Diabetes-induced cardiomyopathy is ameliorated by heat-killed Lactobacillus reuteri GMNL-263 in diabetic rats via the repression of the toll-like receptor 4 pathway
- (2021) Chung-Jen Chiang et al. EUROPEAN JOURNAL OF NUTRITION
- NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages
- (2021) Yuhua Shi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- NLRP3 inflammasome in cancer and metabolic diseases
- (2021) Bhesh Raj Sharma et al. NATURE IMMUNOLOGY
- Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
- (2021) Yun Zhang et al. CARDIOVASCULAR RESEARCH
- Effects of Tranilast on Inflammasome and Macrophage Phenotype in a Mouse Model of Myocardial Infarction
- (2021) Di Qu et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Ketogenic Diet Suppressed T-Regulatory Cells and Promoted Cardiac Fibrosis via Reducing Mitochondria-Associated Membranes and Inhibiting Mitochondrial Function
- (2021) Jun Tao et al. Oxidative Medicine and Cellular Longevity
- Bletilla striata Polysaccharide Promotes Diabetic Wound Healing Through Inhibition of the NLRP3 Inflammasome
- (2021) Yan Zhao et al. Frontiers in Pharmacology
- NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin
- (2021) Rongchuan Yue et al. Cell Death Discovery
- Glibenclamide alleviates β adrenergic receptor activation-induced cardiac inflammation
- (2021) Ning Cao et al. ACTA PHARMACOLOGICA SINICA
- Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis
- (2021) Jiarui Han et al. CELL BIOLOGY AND TOXICOLOGY
- Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway
- (2021) Bei Ren et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways
- (2021) Jianping Yao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Hydrogen gas inhalation ameliorates cardiac remodelling and fibrosis by regulating NLRP3 inflammasome in myocardial infarction rats
- (2021) Chaoqun Nie et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Human umbilical cord mesenchymal stem cells deliver exogenous miR-26a-5p via exosomes to inhibit nucleus pulposus cell pyroptosis through METTL14/NLRP3
- (2021) Xiaoqiu Yuan et al. MOLECULAR MEDICINE
- Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177® (Dapansutrile) in a Mouse Model of Severe Ischemic Cardiomyopathy Due to Non-Reperfused Anterior Wall Myocardial Infarction
- (2021) Joseph Aliaga et al. MOLECULES
- NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: friend or foe?
- (2021) Xu Chen et al. PHARMACOLOGICAL RESEARCH
- Post-myocardial infarction heart failure dysregulates the bone vascular niche
- (2021) Jedrzej Hoffmann et al. Nature Communications
- Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
- (2021) Hui-Ju Tsai et al. Nutrients
- Impact of Camellia japonica Bee Pollen Polyphenols on Hyperuricemia and Gut Microbiota in Potassium Oxonate-Induced Mice
- (2021) Yuanyuan Xu et al. Nutrients
- Exosomes derived from adipose-derived stem cells overexpressing glyoxalase-1 protect endothelial cells and enhance angiogenesis in type 2 diabetic mice with limb ischemia
- (2021) Xing Zhang et al. Stem Cell Research & Therapy
- Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response
- (2021) Namrita Kaur et al. Frontiers in Physiology
- Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy
- (2021) Wenhao Ju et al. Frontiers in Cell and Developmental Biology
- Microtubule associated protein 4 (MAP4) phosphorylation reduces cardiac microvascular density through NLRP3-related pyroptosis
- (2021) Yan-hai Feng et al. Cell Death Discovery
- Focus on ferroptosis, pyroptosis, apoptosis and autophagy of vascular endothelial cells to the strategic targets for the treatment of atherosclerosis
- (2021) Xiaoyan Lin et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Regulation and functions of NLRP3 inflammasome in cardiac fibrosis: Current knowledge and clinical significance
- (2021) Xiaoqing Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention
- (2021) Yi Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular and Cellular Mechanisms Influenced by Postbiotics
- (2021) Rafał Jastrząb et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tetramethylpyrazine alleviates diabetes-induced high platelet response and endothelial adhesion via inhibiting NLRP3 inflammasome activation
- (2021) Haowen Zhang et al. PHYTOMEDICINE
- NLPR3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood–brain barrier integrity in murine stroke
- (2021) Maximilian Bellut et al. Cell Death & Disease
- The Role of the Inflammasome in Heart Failure
- (2021) Jimin Wu et al. Frontiers in Physiology
- NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
- (2021) Yiwen Zhang et al. Frontiers in Immunology
- Ketogenic Diets and Cardio-Metabolic Diseases
- (2021) Weiyue Zhang et al. Frontiers in Endocrinology
- NLRP3 Activation and Its Relationship to Endothelial Dysfunction and Oxidative Stress: Implications for Preeclampsia and Pharmacological Interventions
- (2021) Priscila Rezeck Nunes et al. Cells
- Exacerbated post‐infarct pathological myocardial remodelling in diabetes is associated with impaired autophagy and aggravated NLRP3 inflammasome activation
- (2021) Shuai Mao et al. ESC Heart Failure
- Dietary Strategies to Improve Cardiovascular Health: Focus on Increasing High-Density Lipoprotein Functionality
- (2021) Julia T. Stadler et al. Frontiers in Nutrition
- Targeting the NLRP3 inflammasome in cardiovascular diseases
- (2021) Stefano Toldo et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of Dectin-1 in mice ameliorates cardiac remodeling by suppressing NF-κB/NLRP3 signaling after myocardial infarction
- (2020) Xin Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
- (2020) Yi Tan et al. Nature Reviews Cardiology
- Role of NLRP3-Inflammasome/Caspase-1/Galectin-3 Pathway on Atrial Remodeling in Diabetic Rabbits
- (2020) Xiaohan Wu et al. Journal of Cardiovascular Translational Research
- Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay
- (2020) Huan Chen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Fecal microbiota transplantation in disease therapy
- (2020) Hanna Antushevich CLINICA CHIMICA ACTA
- SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
- (2020) So Ra Kim et al. Nature Communications
- Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat
- (2020) Yebin Xie et al. Frontiers in Physiology
- NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
- (2020) Cheng Zeng et al. Redox Biology
- Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation
- (2020) Shu Song et al. ACTA PHARMACOLOGICA SINICA
- Blocking the IL‐1 receptor reduces cardiac transplant ischemia and reperfusion injury and mitigates CMV‐accelerated chronic rejection
- (2020) Iris K. A. Jones et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Betulin alleviates on myocardial inflammation in diabetes mice via regulating Siti1/NLRP3/NF-κB pathway
- (2020) Yongjin Wen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis
- (2020) Suwen Chen et al. Journal of the American Heart Association
- LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR
- (2020) Yingying Xu et al. CELL CYCLE
- Can nutritional interventions modulate the activation of the NLRP3 inflammasome in chronic kidney disease?
- (2020) Livia Alvarenga et al. FOOD RESEARCH INTERNATIONAL
- Acetylase inhibitor SI-2 is a potent anti-inflammatory agent by inhibiting NLRP3 inflammasome activation
- (2020) Liping Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Gut microbiota, NLR proteins, and intestinal homeostasis
- (2020) Hao Guo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NLRP3 inflammasome in endothelial dysfunction
- (2020) Baochen Bai et al. Cell Death & Disease
- Peroxynitrite/PKR Axis Modulates the NLRP3 Inflammasome of Cardiac Fibroblasts
- (2020) Ting Lan et al. Frontiers in Immunology
- The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice
- (2020) Ri-Feng Gao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
- (2020) Allan L. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond
- (2020) Mark F. McCarty et al. Nutrients
- Divide to conquer: NLRP3 is activated on dispersed trans-Golgi network
- (2019) Kaiwen W. Chen et al. CELL RESEARCH
- Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes
- (2019) Zhen Qiu et al. Journal of Diabetes Research
- Increased gene copy number of DEFA1/DEFA3 worsens sepsis by inducing endothelial pyroptosis
- (2019) QiXing Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse
- (2019) Stefano Toldo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis
- (2019) Xiaomei Teng et al. DIABETOLOGIA
- The Effects of Acute and Chronic Aerobic Activity on the Signaling Pathway of the Inflammasome NLRP3 Complex in Young Men
- (2019) Iman Khakroo Abkenar et al. Medicina-Lithuania
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy
- (2019) Wei Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
- (2019) Humayun Sharif et al. NATURE
- Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
- (2019) Nina Wettschureck et al. PHYSIOLOGICAL REVIEWS
- Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats
- (2019) Qiaoji Qin et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome
- (2019) Yochai Birnbaum et al. BASIC RESEARCH IN CARDIOLOGY
- Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
- (2019) Xueling Li et al. Frontiers in Physiology
- The gut microbiota and diabetic cardiomyopathy in humans
- (2019) M. Bastin et al. DIABETES & METABOLISM
- Sodium butyrate alleviates high-glucose-induced renal glomerular endothelial cells damage via inhibiting pyroptosis
- (2019) Junling Gu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Aerobic Exercise Ameliorates Myocardial Inflammation, Fibrosis and Apoptosis in High-Fat-Diet Rats by Inhibiting P2X7 Purinergic Receptors
- (2019) Xudong Chen et al. Frontiers in Physiology
- IL-1β and Statin Treatment in Patients with Myocardial Infarction and Diabetic Cardiomyopathy
- (2019) Liberale et al. Journal of Clinical Medicine
- Effects and mechanisms of PSS-loaded nanoparticles on coronary microcirculation dysfunction in streptozotocin-induced diabetic cardiomyopathy rats
- (2019) Yongjun Mao et al. BIOMEDICINE & PHARMACOTHERAPY
- Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways
- (2019) Yan Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts
- (2019) Felipe Tapia Cáceres et al. FASEB JOURNAL
- Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway
- (2019) Hong Wei et al. Journal of Diabetes Research
- Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy
- (2018) Maura Knapp et al. ACTA PHARMACOLOGICA SINICA
- The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways
- (2018) Danlu Jiang et al. CANCER LETTERS
- NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
- (2018) Alena Grebe et al. CIRCULATION RESEARCH
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- NLRP3 Inflammasome Activation Contributes to Mechanical Stretch–Induced Endothelial-Mesenchymal Transition and Pulmonary Fibrosis
- (2018) Zhou Lv et al. CRITICAL CARE MEDICINE
- Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation
- (2018) Hailong Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose
- (2018) Xiaohui Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Inflammation and fibrosis
- (2018) Matthias Mack MATRIX BIOLOGY
- Mediterranean Diet, Glucose Homeostasis, and Inflammasome Genetic Variants: The CORDIOPREV Study
- (2018) Irene Roncero-Ramos et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?
- (2018) Timothy A. Simeone et al. NEUROPHARMACOLOGY
- Adherence to Mediterranean Diet and All-Cause Mortality After an Episode of Acute Heart Failure
- (2018) Òscar Miró et al. JACC-Heart Failure
- Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats
- (2018) Yinji Liang et al. Probiotics and Antimicrobial Proteins
- Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
- (2018) Satoshi Ida et al. Cardiovascular Diabetology
- Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy
- (2018) Fan Yang et al. Cell Death & Disease
- SUMO-mediated regulation of NLRP3 modulates inflammasome activity
- (2018) Rachael Barry et al. Nature Communications
- Probiotics modify body weight together with anxiety states via pro-inflammatory factors in HFD-treated Syrian golden hamster
- (2018) Ennio Avolio et al. BEHAVIOURAL BRAIN RESEARCH
- Curcumin augments the cardioprotective effect of metformin in an experimental model of type I diabetes mellitus; Impact of Nrf2/HO-1 and JAK/STAT pathways
- (2018) Eman M. Abdelsamia et al. BIOMEDICINE & PHARMACOTHERAPY
- Cardiac metabolic modulation upon low‐carbohydrate low‐protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized 13 C pyruvate, butyrate, and acetoacetate probes
- (2018) Desiree Abdurrachim et al. DIABETES OBESITY & METABOLISM
- PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
- (2018) Jueqi Chen et al. NATURE
- Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway
- (2018) Dawei Lian et al. PHYTOMEDICINE
- Macrophage-derived foam cells impair endothelial barrier function by inducing endothelial-mesenchymal transition via CCL-4
- (2017) Ying Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Fecal Microbiota Transplantation
- (2017) Arjun Gupta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy
- (2017) Xue Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation
- (2017) Nan Song et al. MOLECULAR CELL
- Redefining the identity of cardiac fibroblasts
- (2017) Michelle D. Tallquist et al. Nature Reviews Cardiology
- Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective
- (2017) Jinfan Tian et al. Oxidative Medicine and Cellular Longevity
- NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
- (2017) Beibei Luo et al. Frontiers in Physiology
- MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1
- (2016) Prince Jeyabal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction
- (2016) Yang Chen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3
- (2016) Hui Song et al. Nature Communications
- Endurance and Resistance Training Affect High Fat Diet-Induced Increase of Ceramides, Inflammasome Expression, and Systemic Inflammation in Mice
- (2016) Cornelia Mardare et al. Journal of Diabetes Research
- Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
- (2016) Constantijn Franssen et al. JACC-Heart Failure
- Immune Cell and Other Noncardiomyocyte Regulation of Cardiac Hypertrophy and Remodeling
- (2015) R. A. Frieler et al. CIRCULATION
- miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy
- (2015) Biao Feng et al. DIABETES
- Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus
- (2015) Eylem Levelt et al. EUROPEAN HEART JOURNAL
- The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
- (2015) Jeremy Dupaul-Chicoine et al. IMMUNITY
- Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial
- (2015) Annelise C. Costanza et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1
- (2015) Yang Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Unknown
- (2015) Fei Yan et al. MOLECULAR MEDICINE
- The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
- (2015) Yun-Hee Youm et al. NATURE MEDICINE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling
- (2015) M Zhang et al. Cell Death & Disease
- The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
- (2014) Susana Vallejo et al. Cardiovascular Diabetology
- DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway
- (2014) Yao Dai et al. CARDIOVASCULAR DRUGS AND THERAPY
- Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat
- (2014) Xiaohong Tracey Gan et al. Circulation-Heart Failure
- The Prevalence of Diabetic Cardiomyopathy: A Population-Based Study in Olmsted County, Minnesota
- (2014) Sanjay Dandamudi et al. JOURNAL OF CARDIAC FAILURE
- Cardiac Fibroblasts Contribute to Myocardial Dysfunction in Mice with Sepsis: The Role of NLRP3 Inflammasome Activation
- (2014) Wenbo Zhang et al. PLoS One
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
- (2014) X Li et al. Cell Death & Disease
- Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
- (2013) Benjamin Wallace Van Tassell et al. AMERICAN JOURNAL OF CARDIOLOGY
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Targeting Interleukin-1 in Heart Disease
- (2013) Benjamin W. Van Tassell et al. CIRCULATION
- Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature
- (2013) Takuya Shida et al. HEART AND VESSELS
- Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome Activation
- (2013) Yiqing Yan et al. IMMUNITY
- Probiotic-fermented purple sweet potato yogurt activates compensatory IGF-IR/PI3K/Akt survival pathways and attenuates cardiac apoptosis in the hearts of spontaneously hypertensive rats
- (2013) PEI-PEI LIN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox
- (2013) Paulo Zoé Costa et al. LIFE SCIENCES
- Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition
- (2012) Jason C. Kovacic et al. CIRCULATION
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention
- (2012) S. Ørn et al. JOURNAL OF INTERNAL MEDICINE
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease
- (2011) Duncan J Campbell et al. Cardiovascular Diabetology
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- HMGB1 Increases Permeability of the Endothelial Cell Monolayer via RAGE and Src Family Tyrosine Kinase Pathways
- (2011) Wenchang Huang et al. INFLAMMATION
- Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats
- (2011) Ri-Ning Tang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells
- (2010) Mohanraj Rajesh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endothelial Cell–Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation of Endothelial-to-Mesenchymal Transition
- (2010) Bambang Widyantoro et al. CIRCULATION
- Control of Intestinal Homeostasis, Colitis, and Colitis-Associated Colorectal Cancer by the Inflammatory Caspases
- (2010) Jeremy Dupaul-Chicoine et al. IMMUNITY
- End-organ dysfunction and cardiovascular outcomes: the role of the microcirculation
- (2009) Christopher J. Lockhart et al. CLINICAL SCIENCE
- Cardiac fibroblasts: At the heart of myocardial remodeling
- (2009) Karen E. Porter et al. PHARMACOLOGY & THERAPEUTICS
- Caspases as therapeutic targets
- (2008) B. Howley et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The cardiovascular influence of interleukin-1β on the expression of bradykinin B1 and B2 receptors
- (2007) A. Riad et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started